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OBJECTIVE — To compare the aerobic exercise capacity and pulmonary function between
athletes with and without type 1 diabetes.
RESEARCH DESIGN AND METHODS — Fifty-one adult age-matched individuals
were assessed in random order to the maximum volume of O2 consumption (VO2peak max)
(ml/kg/min), anaerobic threshold (ml/kg/min), peak pulmonary ventilation (VE), heart rate
(beats per min), time to exhaustion (min), forced vital capacity (FEV) (%), forced expiratory
volumeintheﬁrstsecond(FEV1)(%),totallungcapacity(TLC)(%),andlungdiffusioncapacity
for carbon monoxide (DLCO) (%). Individuals were 27 with type 1 diabetes: 15 athletes (ADM)
and 12 nonathletes (NADM); and 24 healthy individuals: 12 ADM and 12 NADM. Duration of
diabetes was 14.6  6.2 and 15.2  6.7 years in ADM and NADM, respectively.
RESULTS — Vo2peak max was higher in ADM than in NADM (P0.001). The anaerobic thresh-
old was lower in subjects with type 1 diabetes than in control subjects (P0.001). FEV1 was lower
in ADM than in other groups (NADM, athletes control, and nonathletes control, P  0.001).
CONCLUSIONS — Aerobic capacity in subjects with type 1 diabetes with programmed
exerciseissimilartothecapacityofnormalathletesdespiteloweranaerobicthresholdandFEV1.
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I
ndividuals with type 1 diabetes may
have some impaired ﬁtness-related
components and alterations in their
cardiorespiratory responses to exercise.
The association of reduced lung function
with diabetes has been described for
many years (1). The lung may be another
organ adversely affected by diabetes. Pa-
tients with diabetes demonstrate a
restrictive (8–20%) ventilatory defect.
However, some of these data are contro-
versial (2–5).
Inapreviousstudy,wedemonstrated
that nonathletic type 1 diabetic patients
had decreased lung ventilation associated
with decreased maximal O2 consumption
and exercising capacity (6). It is currently
unclear, however, whether the observed
loweraerobicperformanceisafunctionof
a reduced level of habitual activity or im-
pairment in cardiorespiratory or skeletal
musclefunction(7).Inthisarticle,wewill
verify whether our previous ﬁndings in
lung ventilation, maximum volume of O2
consumption (VO2peak max), and exercis-
ing capacity are also present in type 1 di-
abetic patients who engage in regular or
systematic exercise.
RESEARCH DESIGN AND
METHODS— We studied 51 adult
age-matchedindividuals.Theexperimen-
talgroupincluded12athletes(ADM)and
12 nonathletes (NADM) with type 1 dia-
betes (8). The control group included 12
healthy athletes and 12 healthy nonath-
letes. The diabetic groups did not have
clinical chronic diabetes complications or
anemia. The study was approved by the
Ethics Committee of the Federal Univer-
sity of Sa ˜o Paulo (number 0604/06). All
subjects or respective relatives gave writ-
ten, informed consent. Anthropometric,
laboratory (A1C; high-performance liq-
uid chromatography-normal range: 3.5–
6.0%), and microalbuminuria (12-h
overnight immunoturbidimetric method;
normalupto20g/min)testresultswere
recorded at each visit. All individuals
were in a nonfasting state and were in the
diabetic group two hours after their last
routine insulin injection.
Aerobic exercise capacity was con-
ducted using a motorized Life Fitness
treadmill model 9100 HR (Schiller Park,
IL). A metabolic system model assembled
together with a CO2/O2 gas analyzer
(VistaMiniCPX;VacuMedTurboﬁt,Ven-
tura, CA) was used to determine the sub-
ject’s aerobic power (assessed as peak
VEmax).
The test ended (subject showed signs
or symptoms of fatigue) at what we con-
sideredtheVO2peak max(ml/kg/min)ofox-
ygen consumption (aerobic exercise
capacity). O2 consumption, CO2 produc-
tion, and pulmonary ventilation (VE)
were monitored at 30-s intervals. The
VO2peak max was used to deﬁne the sub-
ject’s aerobic capacity. Anaerobic thresh-
old was measured when VE and VCO2
began to increase nonlinearly as com-
pared with VO2 (9).
The time, ﬂow-volume (lung dy-
namic and static volumes curves [Collins
spirometer DS11a; Warren E. Collins,
Braintree, MA]), and lung diffusion ca-
pacity for carbon monoxide (DLCO) were
obtained following the American Tho-
racic Society Pulmonary Function Test
Guidelines (10). Forced vital capacity
(FVC), expiratory volume in the ﬁrst sec-
ond (FEV1), functional residual capacity
(FRC) (open-circuit method of N2 wash-
out), and DLCO (corrected for individual
hemoglobin concentrations) measure-
ments were reported. Inspiratory vol-
umes were considered acceptable when
subjects achieved an inspired volume
above 90% of their vital capacity in all
tests. All spirometric, N2 washout, and
DLCO data were reported as percentages
of the normal predicted values by age,
height, and sex.
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Statistical analysis was performed using
the SPSS 17.0 (Chicago, IL). The variable
curve normality was evaluated using the
Kolmogorov-Smirnov test. The correla-
tion (Spearman or Pearson coefﬁcients)
between variables was accomplished us-
ing the ANOVA test and a Tukey post
hoc analysis. P  0.05 was considered
signiﬁcant.
RESULTS— The anthropometric pa-
rameters were similar between the type 1
diabetes and control groups. A1C was
higher in the NADM than in the ADM
(9.0  1.3 vs. 7.5  6.2%; P  0.05).
Therewerenostatisticaldifferencesinthe
microalbuminuria between diabetic
groups.
VO2peak max was higher in ADM
(42.4  5.5 ml/kg/min) and athletes con-
trol (AC) (44.2  5.0) than in NADM
(34.8  3.3) and nonathletes control
(NAC) (37.8  2.7) (P  0.001). Anaer-
obicthresholdwaslowerinADM(31.7
4.4 ml/kg/min) and NADM (24.6  3.3)
thaninAC(35.94.9)andNAC(28.3
3.0) (P  0.001). FEV1 in AC (102 
0.6%) and NAC (97  0.4%) was higher
than in ADM (89  0.5%) (P  0.001)
(Table 1).
CONCLUSIONS — In this study, we
have shown that athletes with type 1 dia-
betes have a VO2peakmax similar to that of
athletes without diabetes but a lower an-
aerobic threshold than that of athletes
without diabetes.
In a previous study (6), we demon-
strated that nonathletic type 1 diabetic
patients have a lower VO2peak max than
healthy subjects. In the present study, we
conﬁrm these data in nonathletic type 1
diabetic patients, but the defect (low
VO2peak max) was not found in athletes
with type 1 diabetes. These data are in
accordance with a study (11) that com-
pared 128 patients with long-duration
type 1 diabetes and 36 healthy
individuals.
Metabolic issues (such as hyperglyce-
mia and low lactic acid clearance during
and after exercise) and respiratory prob-
lems (the ventilation reached at peak ex-
ercise was lower in proportion to the
reduction in O2 uptake) may relate to re-
duced anaerobic threshold and early fati-
gability or loss of performance (12).
However, we did not ﬁnd a difference in
VO2peak max between type 1 diabetic and
healthy control athletes. Therefore, other
factors besides ventilation may inﬂuence
anaerobic threshold in this diabetic
condition.
All of the individuals in this study
went to heart rate max frequency during
thetest.However,thetype1diabetessed-
entary group had lower maximum heart
rate than the control group, as expected.
Thiswasaninterestingﬁndingandonein
accordance with our previous data (6) in
which the diabetic group showed lower
maximumfrequencyduringexercisethan
normalcontrolsubjects.Thisdefectcould
be corrected with regular exercise since
thediabeticathletewasabletoachievethe
same maximum heart rate as a normal
athlete.
Inthisstudy,wealsofoundthatFEV1
was decreased in type 1 diabetic athletes
compared with other groups. This result
conﬂicts with data found in type 1 dia-
betic nonathletes with the same clinical
characteristics and duration of type 1 di-
abetes but higher A1C than type 1 dia-
betic athletes (13). However, this can
suggest a difﬁcult bronchial adaptation to
airﬂowintheﬁrstsecondofexpirationin
these individuals. Abnormalities in lung
elasticity behavior can be manifestations
of widespread elastin and collagen abnor-
malities in type 1 diabetic patients (14).
Thesealterationshavebeendemonstrated
indiabetesandare,insomerespects,sim-
ilar to those that occur during normal
aging.
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Table 1—Anthropometrics, clinical characteristics, physical capacity parameters, and lung function in the subjects studied
ADM NADM AC NAC
n 15 12 12 12
Age (years) 27.4  5.1 26.5  5.6 27.7  4.0 24.1  5.0
Weight (kg) 70.4  9.2 63.1  9.0 68.0  11.3 65.1  11.2
Height (cm) 174.5  8.2* 164.4  5.8* 172.6  7.1 171.0  7.5
BMI (kg/m
2) 23.0  1.7 23.3  2.8 22.6  2.4 22.1  2.6
TDDM (years) 14.6  6.2 15.2  6.7 — —
A1C (%) 7.5  6.2*† 9.0  1.3* 4.4  0.8† 4.4  0.8
Microalbuminuria (g/min) 10.46  7.2† 11.69  7.53 2.75  3.01† 4.44  3.19
VO2peak max (ml/kg/min) 42.4  5.5*† 34.8  3.3* 44.2  5.0° 37.8  2.7†°
Anaerobic threshold (ml/kg/min) 31.7  4.4*† 24.6  3.3* 35.9  4.9†° 28.3  3.0°
Peak VEmax (btps) 101.8  21.8 91.2  14.3 115.8  13.3 100.4  8.8
Peak heart rate (beats per min) 194.2  7.1 190.1  6.4 198.0  4.9° 192.5  6.9°
Time to exhaustion (min) 13.3  1.5 12.4  1.0 13.6  1.2° 12.1  0.8°
FVC (%) 89  0.74 94  0.86 99  0.98 87  0.24
FEV1 (%) 89  0.51† 96  0.12 102  0.68† 97  0.47
TLC (%) 100  0.77 91  0.78 101  0.14 93  0.99
DLCO (%) 101  0.13 94  0.76 103  0.12 96  0.64
Data are means  SD. TDDM, time from diabetes diagnosis. Height: *ADM  NADM, NADM  AC. A1C: *ADM  NADM, †ADM  AC, ADM  NAC,
NADM  AC, NADM  NAC. Microalbuminuria: †ADM  AC, ADM  NAC, NADM  NAC. VO2peak max: *ADM  NADM, ADM  NAC, NADM 
AC, °AC  NAC. Anaerobic threshold: *ADM  NADM, †ADM  AC, NADM  AC, °AC  NAC, ADM  NAC, NADM  NAC. Peak VEmax: NADM 
AC.Peakheartrate:NADMAC,°ACNAC.Timetoexhaustion:ADMNAC,NADMAC,°ACNAC.FEV1:†ADMAC,ADMNAC.Themean
difference is signiﬁcant at the 0.05 level.
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